EP1169055A1 - Methode d'etablissement de protocoles de soin et de prevention permettant la surveillance clinique des plaies - Google Patents

Methode d'etablissement de protocoles de soin et de prevention permettant la surveillance clinique des plaies

Info

Publication number
EP1169055A1
EP1169055A1 EP00908306A EP00908306A EP1169055A1 EP 1169055 A1 EP1169055 A1 EP 1169055A1 EP 00908306 A EP00908306 A EP 00908306A EP 00908306 A EP00908306 A EP 00908306A EP 1169055 A1 EP1169055 A1 EP 1169055A1
Authority
EP
European Patent Office
Prior art keywords
wound
decision tree
factors
visual
visual decision
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00908306A
Other languages
German (de)
English (en)
Other versions
EP1169055A4 (fr
Inventor
Ronald J. Shannon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Convatec Technologies Inc
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of EP1169055A1 publication Critical patent/EP1169055A1/fr
Publication of EP1169055A4 publication Critical patent/EP1169055A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines

Definitions

  • the present invention relates to methods for consistently designating appropriate treatment protocols for patients, particularly protocols involving wounds or wound prevention.
  • a number of computer programs have been developed wherein a user, for example a care giver, inputs parameters indicative of a patient assessment into a computer and obtains a care plan as an output. Input parameters can include art recognized assessment parameters, such as those recommended by the National Pressure Ulcer Advisory Board.
  • WSIS Wound and Skin Intelligence System
  • Other similar programs have been developed by Johnson & Johnson Medical (a division of Ethicon, Inc.) and Smith & Nephew, Ltd.
  • the present invention provides a method for correlating patient assessment parameters with appropriate treatment protocols.
  • the method provides a visually keyed process to derive a care plan.
  • the process does not require a computer, and when executed with a computer is highly integrated with visual cues.
  • Such a process can be embodied in devices that provide bedside tools to assist the care giver to make evidence-based decisions for the care of individuals, such as individuals at risk of forming wounds or individuals who already have wounds, such as a pressure ulcers.
  • the invention relates to a method of identifying a wound care protocol for a given wound or wound prevention protocol appropriate for a given patient comprising: classifying the wound or patient against a defined scale for a first wound factor, which is defined wound assessment factor or defined wound risk assessment factor to obtain a wound classification; grading the wound or patient against defined scales for one or more second wound factors, which are wound assessment factors or wound risk assessment factors; and operating a visual decision tree device to show a decision or visual decision tree corresponding to the wound classification or to a scale for a wound assessment factor, wherein the visual decision tree device identifies at least one component of a treatment protocol for the graded wound factors.
  • At least one visual decision tree indicates two or more distinct decisions based on the grade of one or more second wound factors.
  • the visual decision tree is a mechanical device.
  • the method can also comprise providing an interactive visual scoring sheet on which markers for the available scores for two or more wound factors are displayed; and marking the appropriate score for the two or more wound factors on the interactive visual scoring sheet, wherein the interactive visual scoring sheet contains a marker associated with one or more ofthe scores identifying an addition to the treatment protocol.
  • the invention relates to a method comprising classifying the wound against a defined wound classification scheme; grading the wound against defined scales for one or more second wound assessment factors; and operating visual decision tree device to show a decision or visual decision tree corresponding to the wound classification or to a grade for a wound assessment factor, wherein at least one visual decision tree produced by the device dictates two or more distinct decisions based on the grade of one or more second wound assessment factors, and wherein the visual decision device identifies a treatment protocol for the wound classification and grades of the second wound assessment factors.
  • one ofthe two visual decision tree devices is selected based on wound classification, and the selected visual decision tree device is operated to show a decision or decision tree corresponding to a grade for exudate amount.
  • the wound classification scheme grades wounds from non-open or closed wounds, to wounds of various thicknesses, to wounds that cannot be graded due to obstructions.
  • the invention in some embodiments, relates to a method of identifying a wound care protocol for a given wound or wound prevention protocol appropriate for a given patient comprising: classifying the wound or patient against a defined scale for a first wound factor, which is defined wound assessment factor or defined wound risk assessment factor to obtain a wound classification; grading the wound or patient against defined scales for one or more second wound factors, which are wound assessment factors or wound risk assessment factors; operating visual decision tree device to show the visual decision tree corresponding to the wound classification or to a scale for a wound assessment factor, wherein at least one visual decision tree dictates two or more distinct decisions based on the grade of one or more second wound factors, and wherein the visual decision tree device identifies at least one component of a treatment protocol for the graded wound factors; and marking a pre-defined display of treatment protocols to identify the components of a treatment protocol identified by the method.
  • the method ofthe invention is operated through a graphical user interface on an electronic processor, resulting in a display of treatment protocols that matches a printed display
  • the invention also relates to a visual decision tree device for identifying a wound care protocol for a given wound or wound prevention protocol appropriate for a given patient comprising: a mechanical or electronic device for identifying and displaying one of at least two decisions or visual decision trees based on one or more inputted wound factors according to a defined scale, wherein the visual decision tree device identifies at least one component of a treatment protocol for the graded wound factors.
  • the sliding card comprises markers corresponding to a defined scale for classifying the wound or patient.
  • one or more sliding cards shows a visual decision tree and wherein the housing comprises a view window through which one or more visual decision trees corresponding to the wound classification can be viewed.
  • the visual decision tree device is mechanical and wherein the slide card can be moved with respect to the housing to view through the view window any one of a plurality of individual decision trees displayed on the sliding card.
  • Figure 1 displays a wound assessment interactive visual scoring sheet.
  • Figure 2 displays a chronic wound management decision tool, which is a type of portable mechanical slide-rule visual decision tree device.
  • Figure 2A displays a schematic of a slide-rule visual decision tree device.
  • Figure 2B displays a first set of two exemplary sliding cards.
  • Figure 2C shows a second set of two exemplary sliding cards.
  • Figure 3 displays a schematic of a modular wound care protocol sheet.
  • Figure 4 displays a Patient Risk Assessment and Nurse Action Record, which is a type of interactive visual scoring sheet.
  • Figure 5 displays a Patient Risk Assessment Evaluation Tool, which is a type of portable mechanical slide-rule decision tree device.
  • Figure 5B displays a third set of two exemplary sliding cards.
  • Figure 6 displays a modular wound prevention protocol sheet.
  • Figure 7 displays a Wound Care and Assessment Record.
  • Figure 8 displays a pressure ulcer pathway decision tool, which is a type of a portable mechanical slide-rule visual decision tree device.
  • Figure 9 displays a wound assessment interactive visual scoring sheet.
  • Figure 10 displays a chronic wound management decision tool, which is a type of portable mechanical slide-rule visual decision tree device.
  • Figure 11 displays a Wound Care and Assessment Record.
  • FIG. 1 relates to an interactive visual scoring sheet 10 that can be used according to a preferred embodiment ofthe present invention.
  • the interactive visual scoring sheet 10 can take substantially the same visually-cued form on the screen of a computer or personal device assistant (PDA). In electronic form, each scoring choice is separately on a viewing screen represented as in the paper example illustrated in FIG. 1.
  • the interactive visual scoring sheet 10 comprises a first defined scale 11 for classifying or grading a wound or patient according to a first wound factor 12 and a second defined scale 13 for classifying or grading the wound or patient for one or more second wound factors 14.
  • the second defined scale 13 can include classifying or grading ofthe wound or patient according to: a defined wound assessment factor, a defined wound risk assessment factor, some other classification of a patient's condition, or any combination of such factors.
  • the first defined scale 11 and the second defined scale 13 can be represented by one or more markers 19 corresponding to one or more stages, grades or classifications.
  • Markers 19 and associated criteria 15 can be indicated on the visual scoring sheet 10, for example, by indicia associated with markers 19, including varying colors, numbers, letters, symbols, texture or any combination thereof.
  • Optional associated criteria is provide a brief indication ofthe classifying or grading criteria.
  • the appropriate score for one or more classifying or grading factors can be marked on the interactive visual scoring sheet 10.
  • the criteria 15 can be indicated in whole or in part on the visual scoring sheet 10, or be referenced to criteria found elsewhere. The presence of at least a shorthand reference to the criteria is preferred.
  • the second defined scales 13 can be with respect to one or more second wound factors 14.
  • Second wound factors 14 can, in some embodiments, be selected from any number of factors including but not limited to: exudate amount, necrotic tissue amount, undermining, color of tissue around wound, granulating tissue, peripheral edema, peripheral induration and pain at wound.
  • second wound factors 14 can include, but are not limited to: sensory perception, moisture, activity, mobility, nutrition and friction & shear. In some embodiments, as shown in FIG.
  • first wound factors 12 and second wound factors 14 can be selected from the group consisting of: depth, exudate amount, exudate type, necrotic tissue amount, necrotic tissue type, undermining, surrounding skin color, granulation, peripheral edema, peripheral induration, pain at wound, nutrition, infection, edges, epithelization, functional ability, compliance and healthy margin.
  • the exemplary wound grading factors selected for FIG. 1 are a subset ofthe exemplary wound grading factors selected for FIG. 9.
  • the selection ofthe particular factors of FIG. 1 as sufficient to predict patient care protocols represents an embodiment ofthe invention.
  • one or more ofthe markers 19 for the first wound factor 12 or second wound factor 14 pertaining to a wound or patient condition can be connected by connecting indicia 16 such as lines or arrows that identify one or more treatment protocol components 17.
  • One or more treatment protocol components 17 may be correlated to one or more markers 19, for example by connecting indicia 16, and may be written or referred to on the interactive visual scoring sheet 10.
  • the interactive visual scoring sheet 10 can form, include or be used in reference to a visual decision tree 18. Exemplary decision trees 18 are shown in FIG. 2.
  • the visual decision tree 18 can comprise connecting indicia 16.
  • the visual decision tree 18 can dictate two or more distinct decisions based on one or both ofthe first or second defined scales 11, 13 to identify a treatment protocol component 17 for the classified or graded factors. In FIG.
  • a first set of markers 19a on a first sliding card 22a are used to indicate values or stages ofthe first or second defined scales 11, 13.
  • a second set of markers 19b are used on a second sliding card 22b to indicate values or stages ofthe first or second defined scales 11, 13 in the example illustrated in FIG. 2.
  • the first defined scale 11 can grade wounds from non- open or closed wounds, to wounds of various thicknesses, to wounds that cannot be graded due to obstructions.
  • the wound is first visually inspected and the particular wound or patient parameters are determined, for example, according to one or more defined scales for classifying or grading 11, 13.
  • the wound or patient parameters can then be recorded by marking or indicating them on the interactive visual scoring sheet 10, for example by checking or circling appropriate markers 19.
  • Connecting indicia 16 and a visual decision tree 18 can then be used to identify appropriate protocol components 17 corresponding to the indicated markers 19.
  • a visual decision tree device 20 is provided.
  • a schematic of a visual decision tree device 20 is provided in FIG. 2A.
  • FIG. 2A A schematic of a visual decision tree device 20 is provided in FIG. 2A.
  • the visual decision tree device 20 is a mechanical slide-rule device made up of a first housing 21A with a first view window 28A and a first sliding card 22a. Hingeably attached HINGE to the first housing 21A is second housing 21B into which slides a second sliding card 22b.
  • the user inputs a value for one or more first 12 or second 14 wound factors according to the markers 19a, 19b for the first or second defined scales 11, 13 displayed on the first or second sliding cards 22a, 22b, for example by adjusting the position ofthe appropriate sliding card 22a or 22b within the appropriate housing 21A or 21B such that an appropriate marker 19a or 19b corresponding to the desired input value is displayed in view.
  • Selection ofthe appropriate housing 21 A or 21B and slide card 22a or 22b is determined in this example by connecting indicia 16 to the "Classification of Wound" score on the visual scoring sheet 10 of FIG. 1.
  • QUESTION 1 (FIG. 2A) identifies which first or second wound factor 12, 14 is used to identify the appropriate marker 19a.
  • the display ofthe appropriate marker 19a aligns the appropriate decision or visual decision tree 18a-18d in the view window 28.
  • QUESTION 2 ofthe displayed visual decision tree identifies a marker 19b for which connecting indicia 16b identify appropriate wound care protocol components 17. In some instances, such as illustrated decision tree 18c, the decision tree identifies the wound care protocol component 17 from the marker 19a.
  • Wound care protocol components 17 can be grouped in modules on a wound care protocol sheet 30, as shown in FIG 3.
  • protocol components 17 for wound care of wound prevention are grouped in alpha-numeric groups or modules 31 that correspond to decision tree 18 outcomes. Based on the decision tree 18 outcomes, one or more protocol components 17 may be followed.
  • the modules 31 can be an alpha-numerically labeled module, can include goals for treatment, multiple alternative therapies and recommended products for treatment.
  • the schematic of FIG. 2A shows a two part visual decision tree devices 20 comprising a housing 21 and a sliding card 22.
  • the housing can comprise a top layer 23 and a bottom layer 24 made of, for example, heavy paper or plastic, joined along a top edge 25 and a bottom edge 26.
  • a view window 28 is cut into the top layer 23.
  • the view window can be cut into the top layer or the bottom layer.
  • the sides ofthe top layer 23 and the bottom layer 24 are left open to allow the sliding card 22 to be inserted and moved within the housing 21.
  • the top layer 23 can have a question QUESTION 1 printed on it, which governs where the operator should slide the sliding card 22 so that the appropriate marker from a first set of markers 19a is indicated in the view window 28.
  • the sliding card 22 is slid within housing 21 to a position with respect to the view window 28 where the QUESTION 1 on the top layer 23 is correctly answered by an appropriate marker 19a.
  • a first set of connecting indicia 16a e.g.
  • arrows points to one or more values for a second set of markers 19b in response to QUESTION 2.
  • the operator selects a value from the second set of markers 19b in response to a second question QUESTION 2 found on the sliding card 22 and performs the protocols (referenced as A, B or C in FIG. 2A at the bottom ofthe sliding card 22) that are indicated by a second set of arrows 16b.
  • the grade on first defined scale 11 on the interactive visual scoring sheet 10 of FIG. 1 identifies whether the slide rule of first housing 21A or the slide rule of second housing 21B shall be used (FIG. 2).
  • the score for alpha second defined scale 13a identifies the position to which the ruler is adjusted.
  • first and second sliding cards 22a, 22b of FIG. 2 and FIG. 2C in the first sliding card 22a, one dialed position (e.g., "0" on defined scale 13a for first sliding card 22a of FIG. 2C) gives a wound care protocol component 17 depending on the score of beta second defined scale 13c.
  • Another dialed position (e.g., "2" on defined scale 13a for second sliding card 22b of FIG. 2C) depends on the score of delta second defined scale 13d.
  • Two dialed positions (e.g., "1” or “3” on defined scale 13a for first sliding card 22a of FIG. 2C) directly indicate wound care protocol components 17.
  • Some dialed positions on the second sliding card depend on gamma second defined scale 13b.
  • additional wound care protocol components 17 are identified on the visual scoring sheet 10 by connecting indicia 16 associated with first defined scale 11 and beta, epsilon, zeta, eta and theta wound care protocol components 13B, 13E-13H (FIG. 1). Shown in FIGs.
  • FIG. 2B and 2C are particular exemplary first slide and second slide cards 22c, 22d and 22a, 22b, (respectively).
  • Some embodiments for example as shown in FIG. 5 and FIG. 5B, can have a third sliding card 22e and a fourth sliding card 22f which can slide independently of each other to align a first marker 19a or a second marker 19b with a first view window 28a and a second view window 28b, respectively.
  • These exemplary slide cards are shown in FIGs 5B and 5C, respectively.
  • FIG. 2B and FIG. 2C display exemplary sets of first and second sliding cards 22a, 22b which can be used to practice the invention.
  • the sliding cards 22a, 22b include separate visual decision trees 18e-181 that can be aligned with a view window of a housing.
  • FIG. 2C displays a set of first and second sliding cards 22a and 22b that include visual decision trees 18m-18t.
  • the first and second sliding cards 22c, 22d of FIG. 2B can be used in the visual decision tree device 20 of FIG. 10.
  • the first and second sliding cards 22a, 22b of FIG. 2C can be used in the visual decision tree device 20 of FIG. 2.
  • FIG. 2B and FIG. 2C display exemplary sets of first and second sliding cards 22a, 22b which can be used to practice the invention.
  • the sliding cards 22a, 22b include separate visual decision trees 18e-181 that can be aligned with a view window of a housing.
  • FIG. 2C displays a set of first and second sliding cards 22a and 22b
  • first and second sliding cards 22c, 22d have markers 19a that correspond to a first defined scale 13a and markers 19b that correspond to one or more second defined scales 13b, 13c, 13d.
  • first and second sliding cards 22a, 22b of FIG. 2C have a first set of markers 19a corresponding to a first defined scale 13a, a second defined scale 13b, a third defined scale 13c and a fourth defined scale 13d, which scales are defined for this example in the interactive visual scoring sheet 10 of FIG. 1.
  • the example displayed in FIG. 2C can be used in the visual decision tree decice 20 of FIG. 2.
  • a patient data sheet 40 can be combined with an interactive visual scoring sheet 10 and a wound care protocol sheet 30 in a patient care into a patient diagnostic tool which can be, for example, a single double sided folder or folded sheet of paper.
  • the patient diagnostic tool can be used in conjunction with one or more visual decision tree devices 20.
  • the interactive visual scoring sheet can have different first defined scale 11 and different second defined scale
  • FIG. 1 FIG. 1 and FIG. 2
  • FIG. 9 show different visual scoring sheets 10 that can be used to practice the invention.
  • FIG. 5, FIG. 8 and FIG. 10 show different visual decision tree devices 20 that can be used to practice the invention.
  • FIG. 3 and FIG. 6 show different wound care protocol sheets 30 that can be used to practice the invention.
  • FIG. 7 and FIG. 11 show different patient data sheets 40 that can be used to practice the invention.
  • the figures are provided as examples of possible embodiments of elements which may be used to practice the invention, and should not be construed to limit the scope ofthe invention.
  • An interactive visual scoring sheet is printed or electronic sheet on which scoring choices of wound factors are displayed in a form in which the scores can be visually marked.
  • a visual decision tree is a representation of two or more decisions, with the appropriate decision indicated visually based on the score of at least one wound factor.
  • a visual decision tree device is a device, electrical or mechanical, which can provide a visual image of a decision or decision tree based on an inputted wound care or wound prevention assessment value.
  • the device produces two or more separate visual images of a decision or decision tree, including at least one decision tree depending on the input value.
  • "inputting" comprises adjusting the mechanical device to correspond to the input value.
  • a wound factor is a wound assessment factor for which there is a defined grading scale or a wound risk assessment factor for which there is a defined grading scale.
  • a method for assessing the status of a patient and derivation of a care plan, or protocol, for wound treatment is as follows.
  • a front cover of a Wound Care & Assessment Record (FIG 7) can be completed and included to identify the patient and care giver and to record dates and details of treatment, or the like.
  • a Wound Assessment Record (Pressure Sore Status Tool), a type of interactive visual scoring sheet (FIG. 1) is completed by circling appropriate assessment scores for each factor (exudate amount, necrotic tissue amount, undermining, surrounding skin color, granulation, peripheral edema, peripheral induration, and pain). Using the interactive visual scoring sheet of FIG.
  • a care giver upon examining a wound, classifies the wound as Stage 3 according to the first defined scale for classification.
  • the Chronic Wound Management Pathway Decision Tool a type of portable mechanical slide-rule visual decision tree device, of FIG. 2 is used as follows: (i) using the Exudate Amount score selected from the interactive visual scoring sheet of FIG.
  • the care giver having assessed the wound follows the decision tree provided in FIG. 1 and FIG. 2 to arrive at a care plan from FIG. 3. Following the wound assessment data detailed in the above example, this process is as follows. First, the caregiver notes that the marker for Stage 3 in the Classification of Wound scale has two arrows connected to it: a vertical arrow (which points to "See Red Side of Nurse Action Guide") and a horizontal arrow that passes through the marker pointing from left to right (which points to "Nurse Action 5"). The vertical arrow requires the care giver to consult the red side ofthe decision tool (i.e. Nurse Action Guide), which corresponds to the top section of FIG. 2. Beginning at "START HERE" in the upper portion ofthe tool represented in FIG.
  • Nurse Action Guide i.e. Nurse Action Guide
  • the care giver slides the card in the housing so that the number determined for Exudate Amount in the wound assessment is showing (i.e. "3" in the example). Once this is done, an arrow on the sliding card points to Nurse Actions 2 and 2C, which are found in FIG. 3, with accompanying text in Sections 2 and 2A of Table 1. The care giver then follows the protocols corresponding to Nurse Actions 2 and 2C.
  • the care giver next visually notes all factors indicated that are intersected by a line with an arrow attached as an endpoint (necrotic tissue amount, surrounding skin color, granulation, peripheral edema, peripheral induration, pain at wound and nutrition). If a line attached to the box is checked or circled then the care giver follows through to the end ofthe arrow where one finds the appropriate nurse action referenced. The care giver then records the nurse action on the modular wound care protocol (e.g., Nurse Action Report (Care Plan) of FIG. 3) by circling it. If a checked or circled box or marker does not have a line attached to it then the care giver is not required to do anything further for that marker.
  • Nurse Action Report Care Plan
  • the care giver follows the care plan and proceeds to take action.
  • the horizontal arrow horizontally intersecting marker 3 for classification of wound and pointing to "Nurse Action 5" indicates that the care giver should also perform Nurse Action 5 (which is found in Section 5 of Table 1).
  • the care giver can examine each marker indicated in the grading scales
  • Table 1 Possible text for modular wound care protocol Sheet (FIG. 3)
  • Shear/friction Apply protective ointment Days Used M T W T F S S or moisture retentive dressing to reduce I I Sensi-Care Protective Barrier friction Days Used M T W T F S S
  • Nutrition altered Nutritional Support ⁇ Hydrosorb Size_ Days Used M T W T F S S
  • the suggested topical treatments will facilitate autolytic debridement.
  • Autolytic debridement is usually not recommended for patients with infected wounds or patients at increased risk of infection.
  • Nurse PRODUCTS Action 4A. If infection is not confirmed, Primary Dressing perform Nurse Action 4B. Wound Hydration
  • Nurse Action 4A Appropriate medical ⁇ DuoDERM Hydroactive Gel treatment for infection should be initiated or Days Used M T W T F S S continued.
  • DuoDERM CGF dressings can be ⁇ Other continued during the treatment of infection at Days Used M T W T F S S the discretion ofthe clinician.
  • Nurse Action 4B Evaluate for signs of Moisture Retentive Dressing infection. If not infected, moisture retentive ⁇ DuoDERM CGF Size dressing should extend beyond reddened area Days Used M T W T F S S to protect skin. ⁇ Other Size_
  • Table 2 Possible text for modular wound care protocol Sheet (FIG. 3)
  • Nurse Action Report (Care Plan) Circle or check off the appropriate treatments and indicated products used.
  • Nutritional Support I I Aloe Vesta Antifungal Ointment
  • Example 2 Wound Prevention
  • a Patient Risk Assessment Evaluation Sheet (FIG. 4), a type of interactive visual scoring sheet, is completed by a care giver using a variation ofthe Braden Scale by circling appropriate assessment scores for each risk factor (sensory perception, moisture, activity, mobility, nutrition and friction & shear).
  • the Slide Rule Pressure Ulcer Pathway Decision Tool of FIG. 5 is used as follows: the slide rule is moved to each respective checked score from the Patient Risk Assessment Record (FIG. 4) for each respective risk factor.
  • the method of practicing the invention is outlined in the example below.
  • the care giver obtains the Patient Risk Assessment Record (FIG. 4) and the Slide Rule Pressure Ulcer Pathway Decision Tool of FIG. 5, and then examines a patient.
  • the care giver uses the Slide Rule Pressure Ulcer Pathway Decision Tool of FIG. 5, and follows the decision tree for moisture.
  • the first and second sliding cards 22e, 22f of FIG. 5 are displayed in FIG. 5B.
  • the care giver performs all nurse actions that apply. For instance, if the patient does not suffer urinary or fecal incontinence, but does perspire the care giver would perform Nurse Action F, but not nurse actions A, B, C, D, or E. Further consulting FIG. 5, the care giver slides the sliding card to an Activity rating of 2 and follows the arrows and protocols indicated in the view window (namely Nurse Action K, but not Nurse Action J since the Braden Scale total score is 15 for this patient).
  • Nurse Action P would be performed by the care giver, but not Nurse Actions O or V.
  • the care giver then consults the Friction and Shear section of FIG. 5. Noting that a score of 3 for Friction & Shear does not appear with any arrows, no further Nurse Action protocols need be performed.
  • Nurse Action protocols F, K and P should be performed by the care giver.
  • Table 3 Possible text for modular wound prevention protocol sheet (FIG. 6)
  • Nurse Action Report Circle or check off the appropriate treatments and indicate products used.
  • AQUACEL Hydrofiber a wound dressing comprising a non-woven pad composed of sodium carboxymethylcellulose fibers.
  • the dressing is highly absorbent and forms a soft gel interacts with wound exudate and forms a soft gel which maintains a moist environment for wound healing.
  • Tubigrip Arthropad is a wrapping bandage designed to provide lasting, effective support with complete freedom of movement for the patient.
  • the Tubigrip Arthropad provides tissue support in the management of soft-tissue injuries and general edema and may be used as a pressure dressing.
  • Carboflex Odor A sterile non-adhesive dressing with an absorbent wound contact layer (containing Alginate and Hydrocolloid), an activated charcoal pad and a smooth water-resistant top layer.
  • DuoDERM Extra Thin highly flexible, control gel formula dressing made for use on dry to lightly exudating wounds.
  • the dressing conforms to the body, cleans by autolytic debridement and is a highly effective secondary dressing for wound fillers.
  • DuoDERM Hydroactive Gel a sterile gel comprising natural hydrocolloids (pectin, sodium carboxymethylcellulose) in a clear, viscous vehicle.
  • DuoDERM Hydroreactive Gel a sterile gel composed of natural hydrocolloids (pectin, sodium carboxymethylcellulose) in a clear, viscous vehicle. This product is designed for the management of partial and full-thickness wounds and creates a moist healing environment around a wound which helps to promote the natural autolytic process of debridement.
  • DuoDERM CGF is a dressing that interacts with wound exudate to produce a soft mass that enables removal ofthe dressing with little or no damage to newly formed tissues.
  • the dressing helps isolate the wound against bacterial, viral (HIV-1 and HBV) and other external contamination and can remain in place up to seven days.
  • Kaltostat a sterile non- woven dressing of calcium-sodium alginate fiber which can absorb wound exudate or saline and convert from a firm gel/fiber mat. The gel forms a moist, warm environment at the wound interface.
  • Kalostat Dressing a highly absorbent calcium alginate dressing derived from natural seaweed designed to absorb exudate and control minor bleeding. The dressing is easy to apply, can remain in place up to seven days, and may be used on moderately to heavily exuding wounds.
  • Lyofoam Foam Dressing A polyurethane foam dressing comprising an absorptive hydrophilic contact surface and a secondary outer foam layer through which the aqueous component can be lost by evaporation.
  • the dressing is freely permeable to gases and water vapor but resists strike-through of aqueous solutions and exudate, as the outer layer has hydrophobic properties.
  • SAF Gel an alginate containing formulation designed for multiple uses. The gel is indicated for use on chronic and acute wounds such as dry wounds, pressure ulcers (Stages I to IV) and stasis ulcers.
  • SAF Clens a wound cleaner that has a dual surfactant formulation designed for cleansing of chronic wounds, including superficial, partial-thickness, dry or nectotic wounds.
  • the wound cleanser is nontoxic, noniritating and comes in no- rinse formula.
  • a hydrocolloid dressing comprising an inner (wound contact) layer of hydrocolloids contained within an adhesive polymer matrix and an outer layer of polyurethane film.
  • the dressing also has a product identification mark (ConvaTec registered tear drop trademark) and a visible (SignaDRESS) change indicator guide printed on the film backing.
  • Sure Press High Compression Bandage and Sure Press Absorbant Padding The SurePress High Compression Bandage System is comprised of two layers: the SurePress High Compression Bandage, a washable bandage made from high- quality blend of cotton-viscose, nylon and LYCRA, and the SurePress Absorbent Padding for use as an underlayer.
  • the System can be used for management of venous leg ulcers and associated conditions, and is contraindicated for the management of arterial and mixed venous/arterial ulcers and legs with an ankle circumference less than 18 cm.
  • Tubipad is made from a layer of polyurethane foam banded to a length of elastic tubular bandage that is used for the protection of heels, elbows and knees.
  • UNNA-FLEX is an elastic bandage that provides compression, for instance to improve venous return.
  • the bandage can be self-adherent or in the form of a boot.

Abstract

La présente invention se rapporte à des méthodes visant à l'établissement cohérent de contrôles de traitements (13A) adaptés à des patients, et notamment des protocoles relatifs aux plaies ou visant à prévenir (16) les plaies. De manière spécifique, l'invention se rapporte à des méthodes dans lesquelles on vérifie l'état d'un patient, et notamment de ses plaies, par rapport à des échelles définies de classification et de graduation (13i). Le résultat de cette vérification est utilisé dans un dispositif à arbre décisionnel visuel aux fins d'identification d'un ou de plusieurs composants d'un protocole de traitement (figure 4).
EP00908306A 1999-01-19 2000-01-19 Methode d'etablissement de protocoles de soin et de prevention permettant la surveillance clinique des plaies Withdrawn EP1169055A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11634999P 1999-01-19 1999-01-19
US116349P 1999-01-19
PCT/US2000/001274 WO2000041714A1 (fr) 1999-01-19 2000-01-19 Methode d'etablissement de protocoles de soin et de prevention permettant la surveillance clinique des plaies

Publications (2)

Publication Number Publication Date
EP1169055A1 true EP1169055A1 (fr) 2002-01-09
EP1169055A4 EP1169055A4 (fr) 2009-10-21

Family

ID=22366641

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00908306A Withdrawn EP1169055A4 (fr) 1999-01-19 2000-01-19 Methode d'etablissement de protocoles de soin et de prevention permettant la surveillance clinique des plaies

Country Status (6)

Country Link
EP (1) EP1169055A4 (fr)
JP (1) JP2002534216A (fr)
AU (1) AU778729B2 (fr)
CA (1) CA2360247A1 (fr)
NZ (1) NZ513074A (fr)
WO (1) WO2000041714A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787363B2 (en) * 1999-02-22 2004-09-07 Haemoscope Corporation Method and apparatus for hemostasis and blood management
ES2697688T3 (es) * 2014-04-02 2019-01-25 Urgo Lab Determinación automática de productos médicos apropiados en función de una clase de lesión
US10575789B2 (en) 2014-12-05 2020-03-03 Ricoh Co., Ltd. Random forest based erythema grading for psoriasis
CN110598966B (zh) * 2019-03-28 2024-01-26 中国辐射防护研究院 一种风险指引的后处理设施中设备的分级方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3747847A (en) * 1972-06-28 1973-07-24 St Joseph S Hospital And Medic Slide rule guide to intravenous therapy
DE2428058A1 (de) * 1974-06-11 1976-01-02 Paul Baettig Verfahren zur berechnung pharmakokinetischer groessen und geraet zur ausuebung des verfahrens
US4189634A (en) * 1976-10-29 1980-02-19 Labove Larry D Slide rule for hyperalimentation dosage computations
US4308450A (en) * 1978-12-22 1981-12-29 Baxter Travenol Laboratories, Inc. Two-piece slide calculator for determining metabolic requirements and parenteral feeding dosages
US5265605A (en) * 1992-06-25 1993-11-30 Afflerbach Denise E Wound assessment method and apparatus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820292A (en) * 1983-10-17 1989-04-11 Enguay Pharmaceutical Associates Anti-microbial sensitivity test and testing stratum
US4799500A (en) * 1986-09-17 1989-01-24 Newbury Renton D Method of and apparatus for treatment of muscle imbalance
CA2046802C (fr) * 1990-08-15 2007-05-22 Donald Zane Fortney Compositions contenant de la protease produite par un vibrion et mode d'utilisation dans l'excision des debris et la guerison de plaies
US5732397A (en) * 1992-03-16 1998-03-24 Lincoln National Risk Management, Inc. Automated decision-making arrangement
US5299121A (en) * 1992-06-04 1994-03-29 Medscreen, Inc. Non-prescription drug medication screening system
US5520912A (en) * 1993-07-02 1996-05-28 Immuno Aktiengesellschaft Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen
US5517405A (en) * 1993-10-14 1996-05-14 Aetna Life And Casualty Company Expert system for providing interactive assistance in solving problems such as health care management
US5706441A (en) * 1995-06-07 1998-01-06 Cigna Health Corporation Method and apparatus for objectively monitoring and assessing the performance of health-care providers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3747847A (en) * 1972-06-28 1973-07-24 St Joseph S Hospital And Medic Slide rule guide to intravenous therapy
DE2428058A1 (de) * 1974-06-11 1976-01-02 Paul Baettig Verfahren zur berechnung pharmakokinetischer groessen und geraet zur ausuebung des verfahrens
US4189634A (en) * 1976-10-29 1980-02-19 Labove Larry D Slide rule for hyperalimentation dosage computations
US4308450A (en) * 1978-12-22 1981-12-29 Baxter Travenol Laboratories, Inc. Two-piece slide calculator for determining metabolic requirements and parenteral feeding dosages
US5265605A (en) * 1992-06-25 1993-11-30 Afflerbach Denise E Wound assessment method and apparatus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0041714A1 *

Also Published As

Publication number Publication date
JP2002534216A (ja) 2002-10-15
WO2000041714A1 (fr) 2000-07-20
AU778729B2 (en) 2004-12-16
CA2360247A1 (fr) 2000-07-20
EP1169055A4 (fr) 2009-10-21
AU2968100A (en) 2000-08-01
WO2000041714A9 (fr) 2002-06-27
NZ513074A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
US7184963B1 (en) Method for determining care and prevention pathways for clinical management of wounds
Hess Clinical guide to skin and wound care
Bergstrom Treatment of Pressure Ulcers: Clinical Prctice Guideline
WO2000043046A2 (fr) Système de gestion de plaies et pansements
US20040049408A1 (en) Process for reducing the cost associated with the prevention and treatment of pressure ulcers
Ayello What does the wound say?: why determining etiology is essential for appropriate wound care
Clothier Assessing and managing skin tears in older people
Amini Role of occupational therapy in wound management
Butler Pediatric skin care: guidelines for assessment, prevention, and treatment.
AU778729B2 (en) Method for determining care and prevention pathways for clinical management of wounds
M Abercrombie et al. Recessive dystrophic epidermolysis bullosa. Part 2: care of the adult patient
Nannery Coping with lymphedema: A practical guide to understanding, treating, and living with lymphedema
Islam Nurses’ knowledge, attitude, and practice regarding pressure ulcer prevention for hospitalized patients at Rajshahi medical college hospital in Bangladesh
Baranoski Skin tears: staying on guard against the enemy of frail skin
Stephen-Haynes Pressure ulcer risk assessment and prevention
Sebastian et al. Body contouring surgery after weight loss
Vera Literature review of kennedy terminal ulcers: Identification, diagnosis, nursing goals, and interventions
Kifer Fast facts for wound care nursing: practical wound management in a nutshell
Ekmark Risky business: Preventing skin breakdown in children with spina bifida
Myers Fast Facts for Wound Care Nursing: Practical Wound Management
Kang et al. Home management of intestinal stoma: An evidence based review
American Medical Association American Medical Association Guide to Home Caregiving
Kalyani et al. A Patient Safety: Preventing Pressure Ulcers
Reddy et al. Healing Wounds, Healthy Skin: A Practical Guide for Patients with Chronic Wounds
Stephen-Haynes Prevention of skin tears: intrinsic and extrinsic factors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010814

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20090921

RIC1 Information provided on ipc code assigned before grant

Ipc: G06G 1/00 20060101ALI20090915BHEP

Ipc: G06F 19/00 20060101ALI20090915BHEP

Ipc: A61K 38/48 20060101AFI20000724BHEP

Ipc: A61B 5/00 20060101ALI20090915BHEP

17Q First examination report despatched

Effective date: 20100226

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CONVATEC TECHNOLOGIES INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130801